Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation, HomologousBone Marrow TransplantationMultiple MyelomaPeripheral Blood Stem Cell TransplantationTransplantation ConditioningMelphalanAntineoplastic Combined Chemotherapy ProtocolsBone MarrowCombined Modality TherapyTreatment OutcomeBone Marrow CellsRemission InductionSalvage TherapyStem CellsDisease-Free SurvivalCyclophosphamideLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationEtoposideBone Marrow PurgingRecurrenceHodgkin DiseaseGraft vs Host DiseaseCarmustineCytarabineHematopoietic Stem CellsMyeloablative AgonistsLiver TransplantationSurvival RateWhole-Body IrradiationGraft SurvivalSurvival AnalysisHematologic NeoplasmsVincristineAntigens, CD34Retrospective StudiesBusulfanThiotepaPrognosisGranulocyte Colony-Stimulating FactorDoxorubicinKidney TransplantationFollow-Up StudiesDexamethasoneTime FactorsLymphoma, Mantle-CellLeukapheresisAmyloidosisCell TransplantationBone and BonesAntineoplastic Agents, AlkylatingAntibodies, Monoclonal, Murine-DerivedThalidomideBoronic AcidsTransplantation ChimeraPyrazinesLymphomaAntineoplastic AgentsTissue DonorsMesenchymal Stem Cell TransplantationLymphoma, FollicularLymphoma, T-Cell, PeripheralPrednisoneNeoplasm, ResidualLeukemia, Myeloid, AcuteAutograftsIfosfamideHematopoiesisCord Blood Stem Cell TransplantationMyelodysplastic SyndromesHeart TransplantationImmunosuppressive AgentsCell DifferentiationInduction ChemotherapyPodophyllotoxinLung TransplantationIdarubicinLeukemiaLymphoma, Large B-Cell, DiffuseBlood Component RemovalAntibodies, MonoclonalCells, CulturedHistocompatibility TestingProspective StudiesMaintenance ChemotherapyFeasibility StudiesTransplantation ImmunologyGraft RejectionLymphoma, B-CellFlow CytometryOrgan TransplantationLeukemia, MyeloidHistocompatibilityBone Marrow DiseasesT-LymphocytesEmbryonic Stem CellsMitoxantrone